ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Modulating Integrin and Growth Factor Signaling With Peptides: Strategies to Synergistically Enhance Bone Tissue Regeneration.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Providing biomaterials with cell-instructive cues represents a major goal in tissue engineering to tailor cell-material interactions and guide tissue regeneration. For bone tissue regeneration, this has been classically addressed by integrating integrin-binding proteins and peptides on different substrates, aiming at mimicking the bone extracellular matrix. However, it has become evident that integrin signaling alone is not sufficient to fully recreate the cellular microenvironment required to effectively drive bone healing, and that growth factors (GFs), such as bone morphogenetic proteins (BMPs), are essential for bone development and growth. Indeed, recent research has demonstrated that integrins engage in synergistic signaling with GF receptors (GFRs). For instance, it is now well established that the osteogenic activity of BMPs can be regulated, and often enhanced, by integrins. These findings have thus encouraged the study of novel multifunctional systems that combine integrin-binding ligands with osteoinductive cues to exploit integrin-GF crosstalk and regenerate bone. This review aims to provide a comprehensive overview of the different mechanisms of signaling between integrins and GFRs, and the existing strategies to harness synergistic effects. A particular focus is put on the recent developments using the well-known integrin-binding RGD peptide and its co-presentation with BMP-derived peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.